Medical Device | April 05, 2022
Agilent joins AMBIC to advance biomanufacturing
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
New line of Waters MaxPeak Premier columns further enhances the analysis by delivering 2x to 3x greater sensitivity than conventional steel columns
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
This pre-packaged release is a ready-to-go solution with powerful, straightforward bioanalysis pipeline support
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts
Data integrity early warning system assists pharmaceutical clients in proactively identifying and managing data integrity challenges in line with regulatory guidelines
Subscribe To Our Newsletter & Stay Updated
